Raising the Bar in Community Cancer Care: Florida Cancer Specialists & Research Institute Radiation Oncology Sites Earn ACR Accreditation

FORT MYERS, Fla., Oct. 8, 2025 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) has been awarded a three-year term of accreditation in radiation oncology for each of its radiation locations, 11 in total, as the result of a recent review by the American College of Radiology® (ACR®).

"Earning ACR accreditation across all of our radiation oncology sites reflects our steadfast commitment to providing the highest standards of safety, precision, and patient-centered care," remarked Medical Director, Radiation Oncology and Radiology Administration Sachin Kamath, MD. "This recognition affirms the dedication of our clinical teams, who ensure every patient receives the same level of excellence—close to home, in the communities where they live."

The following FCS sites renewed their three-year ACR accreditation for radiation services:

• Brooksville, 7154 Medical Center Dr., Spring Hill, FL 34608-1329
• Brownwood, 2955 Brownwood Blvd., Ste 107, The Villages, FL 32163-2040
• Highland, 100 Highland Ave. N, Largo, FL 33770-2542
• Hudson, 7651 Medical Dr., Hudson, FL 34667-6594
• Ocala Cancer Center, 4945 SW 49^th Pl., Ocala, FL 34474-9673
• Tampa Cancer Center, 3402 W. Dr. Martin Luther King Jr. Blvd., Tampa FL 33607-6214
• Trinity Cancer Center, 9320 State Road 54, Trinity, FL 34655-1808
• Villages Cancer Center, 1400 N. US Highway 441, Ste. 540, Lady Lake, FL 32159-8987

The following newly established FCS sites earned their first accreditation for radiation services:

• Orlando Radiation Oncology, 52 W. Gore St., Orlando, FL 32806-1114
• Sanford Radiation Oncology, 2200 W 1^st St., Sanford, FL 32771-1674
• Wesley Chapel Cancer Center, 2895 Hueland Pond Blvd., Suite 100, Wesley Chapel, FL 33543

"This achievement underscores the strength of our program and the quality of services we provide to patients across the state," said FCS Chief Executive Officer Ryan Ciarrocchi. "By meeting the rigorous standards of the American College of Radiology at every one of our centers, we are demonstrating our promise to deliver trusted, accessible, and advanced cancer care to every community we serve."

Radiation oncology (radiation therapy) involves the careful use of high-energy radiation to treat cancer and some benign conditions. A radiation oncologist may use radiation to cure cancer or to relieve a cancer patient's symptoms.

The ACR is the nation's oldest and most widely accepted radiation oncology accrediting body, with over 700 accredited sites, and 30 years of accreditation experience. The ACR gold seal of accreditation represents the highest level of quality and patient safety. It is awarded only to facilities meeting specific requirements based on Practice Guidelines and Technical Standards developed by ACR after a peer-review evaluation by board-certified radiation oncologists and medical physicists who are experts in the field. Patient care and treatment, patient safety, personnel qualifications, adequacy of facility equipment, quality control procedures, and quality assurance programs are assessed. The findings are reported back to the facility and provide the practice with a comprehensive report they can use for continuous practice improvement.

About the American College of Radiology
The American College of Radiology® (ACR®), founded in 1924, is a 42,000-member medical association that advances patient care, medical practice and collaborative results through advocacy, quality standards, research and education. www.acr.org   

About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its robust clinical research program.

FCS provides patients with access to a wide range of clinical trials, positioning it as a leader in research among private oncology practices in Florida and across the country. In fact, before receiving FDA approval, the majority of new cancer drugs in the U.S. were first made available to patients through participation in clinical trials at FCS.

Our outstanding team of highly trained and dedicated physicians is committed to delivering tailored treatment plans that make the best use of cutting-edge precision oncology advancements to enhance patient outcomes.

SOURCE Florida Cancer Specialists & Research Institute